New Owner
Novartis - Spinifex Pharmaceuticals
Novartis acquires Spinifex Pharmaceuticals
Announced: June 29, 2015
Type: Acquisition
Disposition: Separate Entity
Status: Complete
Amount: $ 200,000,000
